Related Experiment Video
Updated: Apr 30, 2026

13:22
Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays
Published on: October 23, 2019
8.5K
Phosphokinase antibody arrays on dendron-coated surface
Ju-Won Kwak1, Hyobin Jeong2, Sun-Ho Han3
1Department of Chemistry, POSTECH, Pohang, Republic of Korea.
Plos One
|May 8, 2014
Summary
Researchers developed a novel dendron-coated phosphokinase antibody array (DPA) for enhanced protein phosphorylation analysis. This new method improves sensitivity and reproducibility, aiding in the study of diseases like Alzheimer's disease (AD).
Area of Science:
- Cellular biology
- Biochemistry
- Neuroscience
Background:
- Intracellular signaling relies on monitoring protein phosphorylation.
- Phosphokinase antibody arrays are key tools in phosphoproteomics for well-characterized phosphorylation.
- Existing methods face challenges in sensitivity and reproducibility.
Purpose of the Study:
- To develop an improved phosphokinase antibody array (DPA) for enhanced protein phosphorylation detection.
- To investigate the utility of DPA in disease models, specifically Alzheimer's disease (AD).
- To analyze signaling pathway deregulation in AD progression using DPA.
Main Methods:
- Antibodies immobilized on a dendron-coated glass slide.
- Utilized self-assembled, conically shaped dendrons for controlled antibody spacing.
- Developed a dendron-coated phosphokinase antibody array (DPA).
Main Results:
- DPA demonstrated minimized steric hindrance and improved antigen-antibody binding kinetics.
- Achieved increased sensitivity, selectivity, and reproducibility in measuring protein phosphorylation.
- Generated phosphorylation profiles of brain tissue from AD model mice, revealing deregulated signaling pathways.
Conclusions:
- The dendron-coated phosphokinase antibody array (DPA) offers superior performance for protein phosphorylation analysis.
- DPA is a valuable tool for phosphoproteomics and studying disease mechanisms.
- The study identified key signaling pathways implicated in Alzheimer's disease progression.

